Genomic determination of CR1 CD35 density polymorphism on erythrocytes of patients with gallbladder carcinoma

World Journal of Gastroenterology

Volumn 10, Issue 23, 2004, Pages 3480-3484

  Jiao, Xing Yuan ^a   Lü, Ming De ^a   Huang, Jie Fu ^a   Liang, Li Jian ^a   Shi, Jing Sen ^b  

^a SUN YAT SEN UNIVERSITY   (China)

^b XI'AN JIAOTONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT COMPONENT C3B RECEPTOR; TYPE II SITE SPECIFIC DEOXYRIBONUCLEASE;

ADULT; ARTICLE; CANCER INFILTRATION; CELL ADHESION; CHOLECYSTECTOMY; CHOLELITHIASIS; CHRONIC CHOLECYSTITIS; CONSANGUINITY; CONTROLLED STUDY; CORRELATION ANALYSIS; DNA POLYMORPHISM; ENZYME DEGRADATION; ERYTHROCYTE; FEMALE; GALLBLADDER CARCINOMA; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MUTATION RATE; POLYMERASE CHAIN REACTION; POSTOPERATIVE PERIOD; PREOPERATIVE EVALUATION; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS;

EID: 9244223027     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v10.i23.3480     Document Type: Article

References (42)

1. Jiao XY, Lü MD, Huang JF. Current advances in the risk factors for gallbladder carcinoma. Zhonghua Putong Waike Zazhi 2002; 17: 117-119
2. Lü MD, Jiao XY. Current status of research on tumor markers of biliary tumors. Zhongguo Shiyong Waike Zazhi 2001; 9 522-523
3. Jiao XY, Li DM, Lü MD, Huang JF, Liang LJ. Significance of nucleolar organizers regions associated proteins of T lymphocytes in diagnosis and monitoring of gallbladder carcinoma. Zhonghua Putong Waike Zazhi 2002; 117: 313-314
4. Zou SQ, Zhang L. Relative risk factors analysis of 3922 cases of gallbladder cancer. Zhonghua Waike Zazhi 2000; 38: 800-805
5. Birmingham DJ, Chen W, Liang G, Schmitt HC, Gavit K, Nagaraja HN. A CR1 polymorphism associated with constitutive erythrocyte CR1 levels affects binding to C4b but not C3b. Immunology 2003; 108: 531-538
6. Rowe JA, Raza A, Diallo DA, Baby M, Poudiougo B, Coulibaly D, Cockburn IA, Middleton J, Lyke KE, Plowe CV, Doumbo OK, Moulds JM. Erythrocyte CR1 expression level does not correlate with a Hind III restriction fragment length polymorphism in africans; implications for studies on malaria susceptibility. Genes Immun 2002; 3: 497-500
7. Zorzetto M, Bombieri C, Ferrarotti I, Medaglia S, Agostini C, Tinelli C, Malerba G, Carrabino N, Beretta A, Casali L, Pozzi E, Pignatti PF, Semenzato G, Cuccia MC, Luisetti M. Complement receptor 1 gene polymorphisms in sarcoidosis. Am J Respir Cell Mol Biol 2002; 27: 17-23
8. Nagayasu E, Ito M, Akaki M, Nakano Y, Kimura M, Looareesuwan S, Aikawa M. CR1 density polymorphism on erythrocytes of falciparum malaria patients in Thailand. Am J Trop Med Hyg 2001; 64: 1-5
9. Moulds JM, Zimmerman PA, Doumbo OK, Kassambara L, Sagara I, Diallo DA, Atkinson JP, Krych-Goldberg M, Hauhart RE, Hourcade DE, McNamara DT, Birmingham DJ, Rowe JA, Moulds JJ, Miller LH. Molecular identification of knops blood group polymorphisms found in long homologous region D of complement receptor 1. Blood 2001; 97: 2879-2885
10. Wang HB, Qian BH, Niu F, Jiang AQ. Changes of genomic density polymorphism and quantitative expression of complement receptor type 1 in patients with liver diseases. Zhonghua Ganzangbing Zazhi 2000; 8: 335-337
11. Wang HB, Zhao XP, Guo F. Changes of quantitative expression, adhering activity and genomic density polymorphism of complement type1 in erythocytes (CR1) of patients with liver cancer. Zhonghua Jianyan Yixue Zazhi 20001; 24: 31-33
12. Jiao XY, Shi JS, Wang JS, Yang JY, He P. Effects of radical cholecystectomy on nutritional and immune status in patients with gallbladder carcinoma. World J Gastroenterol 2000; 6: 445-447
13. Jiao XY, Shi JS, Gao JS, Zhou LS. Determination of levels of cellular immunity and humoral immunity in patients with gallbladder carcinoma. Zhongguo Puwai Jichu Yu Linchuang Zazhi 1999; 4: 227-229
14. Jiao XY, Shi JS, Gao JS, Zhou LS, Han WS, Liu G, Lu Y. Study on the serum IL-2, SIL-2r and CEA levels in patients with gallbladder carcinoma. Zhonghua Gandan Waike Zazhi 1999; 5: 342
15. Shi JS, Wang JS, Liu G, Yu YL, Lu Y, Jiao XY, Yang YJ, Li GC, Han Y. Early diagnosis of primary gallbladder carcinoma. Hepatobiliary Pancreat Dis Int 2002; 1: 273-275
16. Nevin JE, Moran TJ, Kay S, King R. Carcinoma of the gallbladder: staging, treatment, and prognosis. Cancer 1976; 37 141-148
17. Gong FQ, Gao ZY, Wang JB, Liu SG, Liu JQ. Pathologic study of precancerous lesion of the gallbladder. Zhonghua Zhongliu Zazhi 1989; 11: 127-129
18. Cornillet P, Philbert F, Kazatchkine MD, Cohen JHM. Genomic determination of the CR1 (CD35) density polymorphism on erythrocytes using polymerase chain reaction amplification and Hind III restriction enzyme digestion. J Immunol Methods 1991; 136: 193-197
19. Noshiro H, Chijiiwa K, Yamaguchi K, Shimizu S, Sugitani A, Tanaka M. Factors affecting surgical outcome for gallbladder-carcinoma. Hepatogastroenterology 2003; 50: 939-544
20. Wakai T, Shirai Y, Yokoyama N, Ajioka Y, Watanabe H, Hatakeyama K. Depth of subserosal invasion predicts long-term survival after resection in patients with T2 gallbladder carcinoma. Ann Surg Oncol 2003; 10: 447-454
21. Ishikawa T, Horimi T, Shima Y, Okabayashi T, Nishioka Y, Hamada M, Ichikawa J, Tsuji A, Takamatsu M, Morita S. Evaluation of aggressive surgical treatment for advanced carcinoma of the gallbladder. J Hepatobiliary Pancreat Surg 2003; 10: 233-238
22. Nakakubo Y, Miyamoto M, Cho Y, Hida Y, Oshikiri T, Suzuoki M, Hiraoka K, Itoh T, Kondo S, Katoh H. Clinical significance of immune cell infiltration within gallbladder cancer. Br J Cancer 2003; 89: 1736-1742
23. Enomoto T, Todoroki T, Koike N, Kawamoto T, Matsumoto H. Xanthogranulomatous cholecystitis mimicking stage IV gallbladder cancer. Hepatogastroenterology 2003; 50: 1255-1258
24. Jarnagin WR, Ruo L, Little SA, Klimstra D, D'Angelica M, DeMatteo RP, Wagman R, Blumgart LH, Fong Y. Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies. Cancer 2003; 98: 1689-1700
25. Yanagisawa N, Mikami T, Yamashita K, Okayasu I. Microsatellite instability in chronic cholecystitis is indicative of an early stage in gallbladder carcinogenesis. Am J Clin Pathol 2003; 120: 413-417
26. Shukla VK, Adukia TK, Singh SP, Mishra CP, Mishra RN. Micronutrients, antioxidants, and carcinoma of the gallbladder. J Surg Oncol 2003; 84: 31-35
27. Kokudo N, Makuuchi M, Natori T, Sakamoto Y, Yamamoto J, Seki M, Noie T, Sugawara Y, Imamura H, Asahara S, Ikari T. Strategies for surgical treatment of gallbladder carcinoma based on information available before resection. Arch Surg 2003; 138: 741-750
28. Bani-Hani KE, Yaghan RJ, Matalka II, Shatnawi NJ. Gallbladder cancer in northern Jordan. J Gastroenterol Hepatol 2003; 18: 954-959
29. Malik IA. Clinicopathological features and management of gallbladder cancer in pakistan: A prospective study of 233 cases. J Gastroenterol Hepatol 2003; 18: 950-953
30. Andrea C, Francesco C. Squamous-cell and non-squamous-cell carcinomas of the gallbladder have different risk factors. Lancet Oncol 2003; 4: 393-394
31. Hemminki K, Li X. Familial liver and gall bladder cancer a nationwide epidemiological study from Sweden. Gut 2003; 52: 592-596
32. Kondo S, Nimura Y, Kamiya J, Nagino M, Kanai M, Uesaka K, Yuasa N, Sano T, Hayakawa N. Factors influencing postoperative hospital mortality and long-term survival after radical resection for stage IV gallbladder carcinoma. World J Surg 2003; 27: 272-277
33. Haratake J, Kasai T, Makino H. Diffuse mucosal carcinoma of intrahepatic and extrahepatic bile ducts including gallbladder. Pathol Int 2002; 52: 784-788
34. Pandey M. Risk factors for gallbladder cancer: a reappraisal. Eur J Cancer Prev 2003; 12: 15-24
35. Shi JS, Zhou LS, Jiao XY, Lu Y, Hao XY, Han WS, Liu G. Clinical significance of detecting tumor necrosis factor and its receptor in serum and bile in patients with gallbladder cancer and gallstone. Zhonghua Gandan Waike Zazhi 2001; 7: 82-83
36. Misra S, Chaturvedi A, Misra NC, Sharma ID. Carcinoma of the gallbladder. Lancet Oncol 2003; 4: 167-176
37. Parwani AV, Geradts J, Caspers E, Offerhaus GJ, Yeo CJ, Cameron JL, Klimstra DS, Maitra A, Hruban RH, Argani P. Immunohistochemical and genetic analysis of non-small cell and small cell gallbladder carcinoma and their precursor lesions. Mod Pathol 2003; 16: 299-308
38. Rashid A. Cellular and molecular biology of biliary tract cancers. Surg Oncol Clin N Am 2002; 11: 995-1009
39. Toyonaga T, Chijiiwa K, Nakano K, Noshiro H, Yamaguchi K, Sada M, Terasaka R, Konomi K, Nishikata F, Tanaka M. Completion radical surgery after cholecystectomy for accidentally undiagnosed gallbladder carcinoma. World J Surg 2003; 27: 266-271
40. Henson DE, Albores-Saavedra J, Corle D. Carcinoma of the gallbladder carcinoma, histologic types, stage of disease, grade, and survival rates. Cancer 1992; 70: 1493-1497
41. Albores-Saavedra J, Alcantra-Vazquez A, Cruz-Ortiz H, Herrera-Goepfert R. The precursor lesions, of invasive gallbladder carcinoma, hyperplasia, atypical hyperplasia and carcinoma in situ. Cancer 1980; 45: 919-927
42. Fan YZ, Zhang JT, Yang HC, Yang YQ. Expression of MMP-2, TIMP-2 protein and the ratio of MMP-2/TIMP-2 in gallbladder carcinoma and their significance. World J Gastroenterol 2002; 8 1138-1143